Pharma · Private company
Jazz Pharmaceuticals Ireland Limited
Track this companyFree. Adds Jazz Pharmaceuticals Ireland Limited to your Dealase workspace and tells you when its record changes.
Clinical trials107 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials10
- A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLCPHASE2 · RECRUITING · started Oct 12, 2026ClinicalTrials.gov NCT07459634 · fetched Nov 12, 2026
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP269 in Healthy Male and Female ParticipantsPHASE1 · RECRUITING · started Sep 22, 2026ClinicalTrials.gov NCT07813663 · fetched Nov 12, 2026
- A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IHPHASE3 · RECRUITING · started Jul 9, 2026ClinicalTrials.gov NCT07625280 · fetched Nov 12, 2026
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of JZP047 in Healthy ParticipantsPHASE1 · ACTIVE_NOT_RECRUITING · started Feb 3, 2026ClinicalTrials.gov NCT07377539 · fetched Nov 12, 2026
- A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast CancerPHASE2 · RECRUITING · started Sep 24, 2025ClinicalTrials.gov NCT07102381 · fetched Nov 12, 2026
- A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1PHASE1 · TERMINATED · started May 13, 2025ClinicalTrials.gov NCT06961266 · fetched Nov 12, 2026
- A Phase 2 Study of Zanidatamab in Patients With HER2-expressing TumorsPHASE2 · RECRUITING · started Jan 14, 2025ClinicalTrials.gov NCT06695845 · fetched Nov 12, 2026
- Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing SarcomaPHASE1_PHASE2 · RECRUITING · started May 23, 2023ClinicalTrials.gov NCT05734066 · fetched Nov 12, 2026
- Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid TumorsPHASE2 · TERMINATED · started Mar 3, 2022ClinicalTrials.gov NCT05126433 · fetched Nov 12, 2026
- A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract CancersPHASE2 · COMPLETED · started Oct 1, 2020ClinicalTrials.gov NCT04466891 · fetched Nov 12, 2026